Increased secretion of glucagon

PheWeb

E4_GLUCAGONPLUS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 E16.3

Hospital discharge: ICD-9 2514

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 E16.3

Cause of death: ICD-9 2514

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

E4_GLUCAGONPLUS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 E16

Name in latin Hypersecretio glucagoni

Similar endpoints

↥

List of similar endpoints to Increased secretion of glucagon based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	10	5	5
Unadjusted prevalence (%)	0.00	0.00	0.00
Mean age at first event (years)	43.37	48.47	38.27

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_GLUCAGONPLUS – Increased secretion of glucagon
GWS hits:

Survival analyses between endpoints

↥

Plot

before Increased secretion of glucagon
after Increased secretion of glucagon

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Increased secretion of glucagon

↥